Variable | IPM group | Placebo group |
---|---|---|
Haemoglobin level available, n | 290 | 288 |
 Haemoglobin level, g/dl, mean ± SD | 12.1 ± 1.0 | 12.0 ± 1.1 |
 ∆ Haemoglobin, g/dl, mean ± SD | 0.09 ± .91 | 0.08 ± .85 |
Ferritin level available, n | 277 | 276 |
 Ferritin level, µg/l, median (IQR) | 47.7 (30.8–70.4) | 45.2 (28.8–65.8) |
 ∆ Ferritin, µg/l, median (IQR) | 3.0 (−9.9 to 17.7) | 1.3 (−9.4 to 14.6) |
Children with iron deficiency at baseline, na | 77 | 82 |
 Children remaining iron deficient at wk 16, n (%) | 43 (55.8) | 53 (64.6) |
 ∆ Ferritin, µg/l, median (IQR) | 6.1 (2.6–17.5) | 5.9 (−0.1 to 14.5) |
Mean corpuscular volume (MCV) available, n | 290 | 288 |
 MCV, fl, mean ± SD | 74.7 ± 5.4 | 74 ± 5.6 |
 ∆ MCV, fl, mean ± SD | 0.5 ± 2.2 | 0.4 ± 1.9 |
Children with microcytosis at baseline, nb | 147 | 164 |
 Persistent microcytosis at wk 16, n (%) | 133 (87.5) | 148 (87.6) |
 ∆ MCV, fl, mean ± SD | 1.1 (0.7–1.5) | 0.7 (0.4–1.1) |